| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |